(BIIB - Get Report)
target raised at Jefferies. Shares of BIIB now seen reaching $176, Jefferies said. Positive topling Hemophilia data. Buy rating.
target cut at UBS to $10, UBS said. Sentiment likely to trump value in the near term.
estimates cut at Guggenheim through 2013, Guggenheim said. Company is leveraged to lower NGL and Canadian crude prices. Buy rating and $59 price target.
estimates, target reduced at UBS. Shares of HAL now seen reaching $49, according to UBS. Estimates also cut, given sluggish domestic activity. Buy rating.
Kansas City Southern
numbers raised at Credit Suisse. Shares of KSU now seen reaching $100, according to Credit Suisse. Estimates also increased, as cross-border traffic should continue to drive growth. Outperform rating.
estimates, target increased at Credit Suisse. LEN estimates were raised through 2013, Credit Suisse said. Company is realizing higher margins and paying lower taxes. Outperform rating and new $35.50 price target.
numbers lowered at Jefferies. Shares of RDC now seen reaching $40, Jefferies said. Estimates also lowered on September fleet status report. Hold rating.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on